← Back to Search

Motivational Interviewing for Chronic Kidney Failure Adherence

N/A
Recruiting
Led By Ebele M Umeukeje, MD, MPH
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age and older
Receiving hemodialysis treatments
Must not have
Planned transplant within the next 6 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 8, week 24
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if a tailored approach to counseling can help kidney patients be more adherent to their treatments. Patients participate in surveys and counseling sessions.

Who is the study for?
The MoVE Trial is for African American adults who are on hemodialysis for kidney failure and have missed or shortened at least one dialysis session. It's not for those planning a transplant, switching to peritoneal dialysis soon, with severe illness or mental impairment, non-English speakers, without documented non-adherence issues, hospitalized or excused absences from treatment.
What is being tested?
This trial tests if motivational interviewing by health coaches can help patients stick to their hemodialysis schedule. Participants will be randomly placed into two groups: one receiving the intervention and the other not. They'll complete surveys and attend sessions over 24 weeks.
What are the potential side effects?
Since this trial involves motivational interviewing rather than medication, traditional side effects like you'd see with drugs aren't expected. However, participants may experience emotional discomfort discussing personal adherence challenges.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am currently undergoing hemodialysis.
Select...
I have missed or shortened a dialysis session in the last 2 months.
Select...
I have been on hemodialysis for over a month.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am scheduled for a transplant within the next 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 8, week 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 8, week 24 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Dialysis treatment adherence
Secondary study objectives
Change in Apathy
Change in Autonomous Regulation
Change in Autonomy Support
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Participants receiving interventionExperimental Treatment1 Intervention
Motivational interviewing intervention
Group II: Standard of CareActive Control1 Intervention
Standard of Care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Motivational interviewing
2011
Completed Phase 3
~7250

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
902 Previous Clinical Trials
938,351 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,448 Previous Clinical Trials
4,332,254 Total Patients Enrolled
10 Trials studying Kidney Failure
10,720 Patients Enrolled for Kidney Failure
Ebele M Umeukeje, MD, MPHPrincipal InvestigatorVanderbilt University Medical Center
1 Previous Clinical Trials
30 Total Patients Enrolled

Media Library

Motivational interviewing Clinical Trial Eligibility Overview. Trial Name: NCT05735743 — N/A
Kidney Failure Research Study Groups: Standard of Care, Participants receiving intervention
Kidney Failure Clinical Trial 2023: Motivational interviewing Highlights & Side Effects. Trial Name: NCT05735743 — N/A
Motivational interviewing 2023 Treatment Timeline for Medical Study. Trial Name: NCT05735743 — N/A
~100 spots leftby Nov 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top